These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Improvement of cognitive dysfunction after treatment with second-generation antipsychotics. Weiss E; Kemmler G; Fleischhacker WW Arch Gen Psychiatry; 2002 Jun; 59(6):572-3; author reply 573-5. PubMed ID: 12044210 [No Abstract] [Full Text] [Related]
7. An importance of dose in antipsychotic combination therapy for schizophrenia. Suzuki T J Clin Psychopharmacol; 2011 Jun; 31(3):399; author reply 399-400. PubMed ID: 21532376 [No Abstract] [Full Text] [Related]
8. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria. Gómez-Perretta C Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229 [No Abstract] [Full Text] [Related]
9. Olanzapine and haloperidol for residual symptoms. de Haan L; van Beveren N Am J Psychiatry; 2005 Jul; 162(7):1392-3; author reply 1393. PubMed ID: 15994737 [No Abstract] [Full Text] [Related]
19. Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate. Adetunji B; Basil B; Mathews M; Williams A; Osinowo T J Clin Psychiatry; 2006 Mar; 67(3):497; author reply 497-8. PubMed ID: 16649843 [No Abstract] [Full Text] [Related]
20. Use of long-acting risperidone. Pinninti NR; Mago R Psychiatr Serv; 2005 Jan; 56(1):105; author reply 106-7. PubMed ID: 15637204 [No Abstract] [Full Text] [Related] [Next] [New Search]